Global Artificial Blood Vessel Market Size Study, By Polymer Type, By End-Users, By Application, and Regional Forecasts 2022-2032

Description

Global Artificial Blood Vessel Market was valued at approximately USD 2.08 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.36% during the forecast period 2024-2032. Artificial blood vessels are synthetic or bioengineered conduits designed to replace or repair damaged blood vessels, particularly in patients requiring bypass surgeries or those suffering from vascular diseases. These vessels are often made from materials such as polymers or biological tissues, providing a promising alternative to autologous grafts, thereby improving patient outcomes.

The Global Artificial Blood Vessel Market is driven by the increasing prevalence of cardiovascular diseases, which has fueled the demand for vascular grafts. Advances in tissue engineering and the growing preference for minimally invasive surgical procedures further bolster market growth. Additionally, the rising aging population globally is contributing to the increased need for vascular grafts, as older adults are more prone to cardiovascular and vascular diseases. However, the market faces challenges such as the high cost of synthetic grafts and potential complications associated with their use, which may hinder market expansion.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America currently leads the Artificial Blood Vessel Market, due to its advanced healthcare infrastructure, widespread adoption of innovative medical technologies, and a substantial patient population. The Asia-Pacific region is poised to witness the fastest growth, driven by the rising incidence of cardiovascular diseases, expanding healthcare infrastructure, and increased investments in medical research. Moreover, the growing awareness and accessibility of advanced treatment options in this region are further contributing to market expansion.

Major market players included in this report are:

Braun Melsungen
Becton Dickinson and Company
Cook Medical Incorporated
LeMaitre Vascular Inc.
W. L. Gore and Associates
Jotec GmbH
Humacyte Inc.
Techshot Inc.
Medtronic plc
Terumo Medical Corporation

The detailed segments and sub-segment of the market are explained below:

By Polymer Type

Polydioxanone
Elastomer
Polyethylene Terephthalate
Others

By End-Users

Hospitals
Cardiac Catheterization Laboratories
Ambulatory Surgical Centers
Specialty Clinics
Others

By Application

Aortic Disease
Peripheral Artery Disease
Hemodialysis

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of the competitive structure of the market.
Demand-side and supply-side analysis of the market

Chapter 1. Global Artificial Blood Vessel Market Executive Summary

1.1. Global Artificial Blood Vessel Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Polymer Type
- 1.3.2. By End-Users
- 1.3.3. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Artificial Blood Vessel Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Artificial Blood Vessel Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising Prevalence of Cardiovascular Diseases
- 3.1.2. Advancements in Tissue Engineering
- 3.1.3. Increasing Demand for Minimally Invasive Surgeries
3.2. Market Challenges
- 3.2.1. High Costs Associated with Synthetic Grafts
- 3.2.2. Potential Complications Related to Synthetic Grafts
3.3. Market Opportunities
- 3.3.1. Development of Advanced Biomaterials
- 3.3.2. Government Support for R&D
- 3.3.3. Adoption of 3D Printing Technology

Chapter 4. Global Artificial Blood Vessel Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Artificial Blood Vessel Market Size & Forecasts by Polymer Type 2022-2032

5.1. Segment Dashboard
5.2. Global Artificial Blood Vessel Market: Polymer Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Polydioxanone
- 5.2.2. Elastomer
- 5.2.3. Polyethylene Terephthalate
- 5.2.4. Others

Chapter 6. Global Artificial Blood Vessel Market Size & Forecasts by End-Users 2022-2032

6.1. Segment Dashboard
6.2. Global Artificial Blood Vessel Market: End-Users Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Hospitals
- 6.2.2. Cardiac Catheterization Laboratories
- 6.2.3. Ambulatory Surgical Centers
- 6.2.4. Specialty Clinics
- 6.2.5. Others

Chapter 7. Global Artificial Blood Vessel Market Size & Forecasts by Application 2022-2032

7.1. Segment Dashboard
7.2. Global Artificial Blood Vessel Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Aortic Disease
- 7.2.2. Peripheral Artery Disease
- 7.2.3. Hemodialysis

Chapter 8. Global Artificial Blood Vessel Market Size & Forecasts by Region 2022-2032

8.1. North America Artificial Blood Vessel Market
- 8.1.1. U.S. Artificial Blood Vessel Market
  - 8.1.1.1. Polymer Type breakdown size & forecasts, 2022-2032
  - 8.1.1.2. End-Users breakdown size & forecasts, 2022-2032
  - 8.1.1.3. Application breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Artificial Blood Vessel Market
8.2. Europe Artificial Blood Vessel Market
- 8.2.1. U.K. Artificial Blood Vessel Market
- 8.2.2. Germany Artificial Blood Vessel Market
- 8.2.3. France Artificial Blood Vessel Market
- 8.2.4. Spain Artificial Blood Vessel Market
- 8.2.5. Italy Artificial Blood Vessel Market
- 8.2.6. Rest of Europe Artificial Blood Vessel Market
8.3. Asia-Pacific Artificial Blood Vessel Market
- 8.3.1. China Artificial Blood Vessel Market
- 8.3.2. India Artificial Blood Vessel Market
- 8.3.3. Japan Artificial Blood Vessel Market
- 8.3.4. Australia Artificial Blood Vessel Market
- 8.3.5. South Korea Artificial Blood Vessel Market
- 8.3.6. Rest of Asia Pacific Artificial Blood Vessel Market
8.4. Latin America Artificial Blood Vessel Market
- 8.4.1. Brazil Artificial Blood Vessel Market
- 8.4.2. Mexico Artificial Blood Vessel Market
- 8.4.3. Rest of Latin America Artificial Blood Vessel Market
8.5. Middle East & Africa Artificial Blood Vessel Market
- 8.5.1. Saudi Arabia Artificial Blood Vessel Market
- 8.5.2. South Africa Artificial Blood Vessel Market
- 8.5.3. Rest of Middle East & Africa Artificial Blood Vessel Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Braun Melsungen
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Becton, Dickinson and Company
- 9.3.3. Cook Medical Incorporated
- 9.3.4. LeMaitre Vascular Inc.
- 9.3.5. W. L. Gore and Associates
- 9.3.6. Jotec GmbH
- 9.3.7. Humacyte Inc.
- 9.3.8. Techshot Inc.
- 9.3.9. Medtronic plc
- 9.3.10. Terumo Medical Corporation

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes